Tenecteplase Knocking on the Door

Stroke. 2018 Sep;49(9):2276-2277. doi: 10.1161/STROKEAHA.118.022318.

Authors

Michael D Hill¹, Patrik Michel²

Affiliations

¹ From the Departments of Clinical Neurosciences, Medicine, Radiology and Community Health Sciences, Hotchkiss Brain Institute, University of Calgary and Foothills Medical Center, Alberta, Canada (M.D.H.).
² Department of Neurology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland (P.M.).

PMID: 30018162
DOI: 10.1161/STROKEAHA.118.022318

No abstract available

Keywords: endovascular treatment; reperfusion; stroke; tenecteplase; tissue-type plasminogen activator.

MeSH terms

Fibrinolytic Agents / therapeutic use*
Humans
Stroke / drug therapy*
Tenecteplase / therapeutic use*
Thrombolytic Therapy
Tissue Plasminogen Activator / therapeutic use

Substances

Fibrinolytic Agents
Tissue Plasminogen Activator
Tenecteplase